Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue City, Viet Nam

被引:15
|
作者
Kaljee, Linda M. [1 ]
Pham, Van
Son, Nguyen Dinh
Hoa, Nguyen Thai
Thiem, Vu Dinh
Canh, Do Gia
Kim Thoa, Le Thi
Ali, Mohammad
Ochiai, Rion Leon
Danovaro-Holliday, M. Carolina
Acosta, Camilo J.
Stanton, Bonita
Clemens, John
机构
[1] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[3] Prov Prevent Med Ctr, Hue City, Thua Thien, Vietnam
[4] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[5] Ha Noi Med Univ, Hanoi, Vietnam
[6] Int Vaccine Inst, Seoul, South Korea
[7] Wayne State Univ, Sch Med, Carman & Ann Adams Dept Pediat, Detroit, MI USA
关键词
children/adolescents; enteric disease; vaccination; typhoid fever; Viet Nam;
D O I
10.1111/j.1365-3156.2006.01751.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES To identify demand for Vi typhoid fever vaccine for school-age children; obstacles and enabling factors for vaccine delivery; and socio-behavioural factors associated with trial participation and possible predictors of future vaccine acceptance, in Hue City, Viet Nam. METHODS Pre- and post-trial surveys of randomly selected households with children aged 6-17 years. Simple multinomial logistic analyses for ratios of relative risks (RRR) and significance on trial participation by demographics and variables related to typhoid fever, vaccination, and pre-trial experiences with information and consents. Multiple logistic regressions to assess differences in participation based on child's characteristics. RESULTS As many as 62.6% of households let all school age children participate, 10.2% let some participate, and 26.8% let none of their children participate in the trial. Factors associated with all children participating included past use of healthcare facilities (RRR, 0.45; 95% CI, 0.24-0.83), knowledge of vaccines (RRR, 0.17; 95% CI, 0.03-0.86), and perceived causes of typhoid fever (RRR, 0.90; 95% CI, 0.81-0.99). Factors associated with some children participating included utilization of healthcare facilities (RRR, 0.08; 95% CI, 0.01-0.66) and perceived severity of typhoid fever (RRR, 0.64; 95% CI 0.46-0.88). Participation was associated with satisfaction regarding pre-vaccination information and consent procedures. Children and adolescents were active decision-makers. Only 14 of 461 (2.2%) respondents would not use the Vi vaccine in the future for their child(ren). CONCLUSIONS Inter-related factors contribute to participation in a clinical vaccine trial, which may differ from desire to participate in a public health campaign. Educational campaigns need to be targeted to children and adolescents, and consideration for assent procedures for minors. Obtaining informed consent may affect trial participation within a social and political system unaccustomed to these procedures.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 17 条
  • [1] Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine in Kolkata, India
    Sur, Dipika
    Manna, Byomkesh
    Chakrabarty, Nandini
    Kaljee, Linda M.
    Riel, Rosemary
    Pach, Alfred
    Kanungo, Suman
    Deen, Jacqueline
    Ochiai, R. Leon
    Clemens, John
    Bhattacharya, S. K.
    HUMAN VACCINES, 2009, 5 (09): : 614 - 620
  • [2] Development of a synthetic Vi polysaccharide vaccine for typhoid fever
    Ni, Yawei
    Springer, Michael J.
    Guo, Jianhua
    Finger-Baker, Isaac
    Wilson, James P.
    Cobb, Ronald R.
    Turner, Debra
    Tizard, Ian
    VACCINE, 2017, 35 (51) : 7121 - 7126
  • [3] Acceptability and accessibility of a shigellosis vaccine in Nha Trang city of Viet Nam
    Kaljee, LM
    Genberg, BL
    von Seidlein, L
    Canh, DG
    Thoa, LTK
    Thiem, VD
    Tho, LH
    Minh, TT
    Trach, DD
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2004, 22 (02) : 150 - 158
  • [4] Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania
    Kaljee, Linda M.
    Pach, Alfred
    Thriemer, Kamala
    Ley, Benedikt
    Jiddawi, Mohamed
    Puri, Mahesh
    Ochiai, Leon
    Wierzba, Thomas
    Clemens, John
    Ali, Said M.
    VACCINE, 2013, 31 (29) : 2994 - 2999
  • [5] Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan
    Khan, M. Imran
    Soofi, Sajid Bashir
    Ochiai, R. Leon
    Habib, Mohammad Atif
    Sahito, Shah Muhammad
    Nizami, S. Qamaruddin
    Acosta, Camilo J.
    Clemens, John D.
    Bhutta, Zulfiqar A.
    VACCINE, 2012, 30 (36) : 5389 - 5395
  • [6] Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up
    Acosta, CJ
    Yang, HH
    Wang, N
    Gao, Q
    Deng, Q
    Ma, XL
    Zhou, BD
    Wei, L
    Danovaro-Holliday, MC
    Ochiai, RL
    Wang, XY
    Kim, DR
    Xu, ZY
    Dong, BQ
    Galindo, CM
    Clemens, JD
    VACCINE, 2005, 23 (48-49) : 5618 - 5623
  • [7] A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial
    Jin Yang
    Camilo J Acosta
    Guo-ai Si
    Jun Zeng
    Cui-yun Li
    Da-bin Liang
    R Leon Ochiai
    Anne-Laure Page
    M Carolina Danovaro-Holliday
    Jie Zhang
    Bao-de Zhou
    He-zhuang Liao
    Ming-liu Wang
    Dong-mei Tan
    Zhen-zhu Tang
    Jian Gong
    Jin-Kyung Park
    Mohammad Ali
    Bernard Ivanoff
    Gui-chen Liang
    Hong-hui Yang
    Tikki Pang
    Zhi-yi Xu
    Allan Donner
    Claudia M Galindo
    Bai-qing Dong
    John D Clemens
    BMC Public Health, 5
  • [8] Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial
    Ali, Mohammad
    Sur, Dipika
    Kanungo, Suman
    Qadri, Firdausi
    Kim, Deok Ryun
    Islam, Taufiqul
    Im, Justin
    Ahmmed, Faisal
    Chon, Yun
    Khan, Ashraful Islam
    Zaman, K.
    Marks, Florian
    Dutta, Shanta
    Bhattacharya, Sujit K.
    Clemens, John D.
    INTERNATIONAL HEALTH, 2020, 12 (01): : 36 - 42
  • [9] Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform
    Agtini, M. D.
    Ochiai, R. L.
    Soeharno, R.
    Lee, H. J.
    Sundoro, J.
    Hadinegoro, S. R.
    Han, O. P.
    Tana, L.
    Halim, F. X. S.
    Ghani, L.
    Delima
    Lestari, W.
    Sintawati, F. X.
    Kusumawardani, N.
    Malik, R.
    Santoso, T. S.
    Nadjib, M.
    Soeroso, S.
    Wangsasaputra, F.
    Ali, M.
    Ivanoff, B.
    Galindo, C. M.
    Pang, T.
    Clemens, J. D.
    Suwandono, A.
    Acosta, C. J.
    PUBLIC HEALTH, 2006, 120 (11) : 1081 - 1087
  • [10] Salmonella Paratyphi A Outer Membrane Vesicles Displaying Vi Polysaccharide as a Multivalent Vaccine against Enteric Fever
    Gasperini, G.
    Alfini, R.
    Arato, V
    Mancini, F.
    Aruta, M. G.
    Kanvatirth, P.
    Pickard, D.
    Necchi, F.
    Saul, A.
    Rossi, O.
    Micoli, F.
    Mastroeni, P.
    INFECTION AND IMMUNITY, 2021, 89 (04)